| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |